NHAS
LKFT

Novo Holdings A/S’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Novo Holdings A/S’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-97,481
Closed -$12.6M – 31
2019
Q2 		$12.6M Hold
97,481
– – 1.76% 14
2019
Q1 		$11.5M Buy
97,481
+10,000
+11% +$1.01M 1.7% 12
2018
Q4 		$8.03M Hold
87,481
– – 1.13% 14
2018
Q3 		$9.84M Buy
+87,481
New +$9.24M 0.78% 16

Other funds holding LKFT

Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Novo Holdings A/S's LKFT Position: Q3 2019 in Review

Novo Holdings A/S sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q3 2019, closing a stake of 97,481 shares — an estimated $12.6M sold.

Novo Holdings A/S first reported a position in LKFT in Q3 2018 and held it in 4 quarters. The position peaked at $12.6M in Q2 2019. 111 funds tracked by Wall St. Rank hold LKFT as of Q3 2019.

  • Novo Holdings A/S reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q3 2019 after selling out during the quarter.
  • Novo Holdings A/S sold 97,481 Lakefront Biotherapeutics American Depositary Shares shares in Q3 2019, an estimated $12.6M.
  • Novo Holdings A/S first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q3 2018 and held it in 4 quarters.
  • Novo Holdings A/S's Lakefront Biotherapeutics American Depositary Shares position peaked at $12.6M in Q2 2019.
  • 111 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q3 2019.

Based on Novo Holdings A/S's 13F filing for Q3 2019, filed 14 Nov 2019.